Lymphovascular invasion and nodal positivity may identify candidates for adjuvant nivolumab in high-risk muscle-invasive urothelial carcinoma.
- DOI
- 10.1016/j.urolonc.2026.08.012
- Published
- 2026 Sep 24
- Container
- Urologic oncology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.urolonc.2026.08.012,
title = {Lymphovascular invasion and nodal positivity may identify candidates for adjuvant nivolumab in high-risk muscle-invasive urothelial carcinoma.},
author = {Shimoda H and Numao N and Oki R and Urasaki T and Tamiya T and Takemura K and Fujiwara R and Inoue M and Miura Y and Yonese J},
year = {2026},
journal = {Urologic oncology},
doi = {10.1016/j.urolonc.2026.08.012},
url = {https://doi.org/10.1016/j.urolonc.2026.08.012}
}RIS
TY - JOUR TI - Lymphovascular invasion and nodal positivity may identify candidates for adjuvant nivolumab in high-risk muscle-invasive urothelial carcinoma. AU - Shimoda H AU - Numao N AU - Oki R AU - Urasaki T AU - Tamiya T AU - Takemura K AU - Fujiwara R AU - Inoue M AU - Miura Y AU - Yonese J PY - 2026 JO - Urologic oncology DO - 10.1016/j.urolonc.2026.08.012 UR - https://doi.org/10.1016/j.urolonc.2026.08.012 ER -
APA
H, S., N, N., R, O., T, U., T, T., K, T., R, F., M, I., Y, M., & J, Y. (2026). Lymphovascular invasion and nodal positivity may identify candidates for adjuvant nivolumab in high-risk muscle-invasive urothelial carcinoma.. Urologic oncology. https://doi.org/10.1016/j.urolonc.2026.08.012
Source records
- pubmed · retrieved 2026-09-25T13:54:05.154Z